Multiple sclerosis as a generalized CNS disease--comparative microarray analysis of normal appearing white matter and lesions in secondary progressive MS

Journal of Neuroimmunology
R L LindbergD Leppert

Abstract

We used microarrays to compare the gene expression profile in active lesions and donor-matched normal appearing white matter (NAWM) from brain autopsy samples of patients with secondary progressive multiple sclerosis (MS) with that from controls who died from non-neurological diseases. The 123 genes in lesions, and 47 genes in NAWM(MS) were differentially expressed. Lesions distinguished from NAWM(MS) by a higher expression of genes related to immunoglobulin synthesis and neuroglial differentiation, while cellular immune response elements were equally dysregulated in both tissue compartments. Current results provide molecular evidence of a continuum of dysfunctional homeostasis and inflammatory changes between lesions and NAWM(MS), and support the concept of MS pathogenesis being a generalised process that involves the entire CNS.

References

Aug 1, 1991·Journal of Neuroscience Research·M De LeonE M Shooter
Jan 1, 1996·Brain Research. Molecular Brain Research·R PoddarP K Sarkar
Oct 1, 1996·Genome Research·U E GibsonP M Williams
Dec 1, 1996·Nature Biotechnology·D J LockhartE L Brown
May 21, 1999·Multiple Sclerosis : Clinical and Laboratory Research·J C FultonD L Kolson
Sep 11, 1999·Annals of Neurology·L W WhitneyW E Biddison
Mar 29, 2000·Neuropathology and Applied Neurobiology·P van der Valk, C J De Groot
Nov 18, 2000·The New England Journal of Medicine·C ConfavreuxP Adeleine
Apr 5, 2001·Trends in Molecular Medicine·H LassmannC Lucchinetti
May 22, 2001·Molecular Biology of the Cell·L BlavierV Kaartinen
Jun 13, 2001·Neurology·UNKNOWN Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-Beta-1a in MS (SPECTRIMS) Study Group
Jan 5, 2002·Journal of Physiology, Paris·Kerstin KrieglsteinKlaus Unsicker
May 9, 2002·Journal of the Neurological Sciences·Xue MingPeter C Dowling
Aug 31, 2002·Glia·Gary A Rosenberg
Nov 1, 2002·The New England Journal of Medicine·David A Dyment, George C Ebers
Jan 23, 2003·Brain : a Journal of Neurology·M FilippiA Falini
Jan 31, 2003·Annals of Neurology·Raju KapoorKenneth J Smith
Feb 1, 2003·Journal of the Neurological Sciences·C BjartmarB D Trapp
Apr 3, 2003·Brain Research. Molecular Brain Research·Goutam Chakraborty, Robert Ledeen
Apr 12, 2003·Brain : a Journal of Neurology·Marcin P MyckoKrzysztof W Selmaj
Jun 5, 2003·Annals of Neurology·Mario H J VogtLex Nagelkerken
Nov 20, 2003·Brain Research. Molecular Brain Research·Lotti TajouriLyn R Griffiths

❮ Previous
Next ❯

Citations

Sep 20, 2005·Journal of Neurology·Ludwig KapposRaija L P Lindberg
Oct 16, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Alejandra Borjabad, David J Volsky
Nov 26, 2013·Nature Neuroscience·Jimmy L HuynhPatrizia Casaccia
Sep 13, 2011·Brain : a Journal of Neurology·Farshid NoorbakhshChristopher Power
Oct 16, 2012·Brain : a Journal of Neurology·James KolasinskiHeidi Johansen-Berg
Jan 14, 2009·Molecular and Cellular Biology·Rosanna Pescini GobertRob Hooft van Huijsduijnen
Jun 24, 2008·BMC Systems Biology·Joaquín GoñiPablo Villoslada
Jan 30, 2014·PloS One·Barbara B R RaddatzReiner Ulrich
Jun 17, 2014·PloS One·Pi GuoKe Li
May 11, 2005·Pharmacogenomics·Sergio E Baranzini, Jorge R Oksenberg
May 26, 2012·Journal of Neuroimmunology·Alex Sánchez-PlaManuel Comabella
Dec 2, 2011·Journal of Neuroimmunology·Vaibhav SinghMarcel P Stoop
Mar 26, 2005·Immunological Reviews·David A HaflerClare Baecher-Allan
Nov 1, 2012·Proteomics. Clinical Applications·Laura F DagleyAnthony W Purcell
Mar 27, 2016·Experimental Neurology·Natalie A Wheeler, Babette Fuss
Aug 30, 2008·Cellular & Molecular Biology Letters·Joel N H Stern, Derin B Keskin
Aug 9, 2015·Neuroscience Bulletin·Peizhou Liang, Weidong Le
Sep 1, 2005·Journal of Neuroimmunology·Guy Haskin FernaldSergio E Baranzini
Apr 3, 2007·Journal of Neuroimmunology·Manuel Comabella, Roland Martin
Jan 28, 2017·Expert Review of Neurotherapeutics·Ethan HollingsworthJaime Imitola
Dec 9, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Seema Patel, Abdur Rauf
Jun 24, 2005·Genes and Immunity·J R Oksenberg, L F Barcellos
Nov 15, 2017·Developmental Neurobiology·Dongchao XuMengsheng Qiu
Jun 20, 2007·Electrophoresis·Bruce I SodowichCraig Burns
Jan 14, 2018·Annals of Neurology·Arman EshaghiUNKNOWN MAGNIMS study group
Jun 11, 2008·Nature Reviews. Genetics·Jorge R OksenbergStephen L Hauser
Feb 3, 2009·Journal of Cellular and Molecular Medicine·Reiner UlrichWolfgang Baumgärtner
Feb 27, 2009·Brain Pathology·Yi Yuen WangMark Cook
May 14, 2005·Current Opinion in Neurology·Saleh M Ibrahim, Ralf Gold
Dec 5, 2006·Expert Review of Molecular Diagnostics·Raija L P Lindberg, Ludwig Kappos
Sep 22, 2020·Network and Systems Medicine·Tobias FrischZsolt Illes
Aug 28, 2020·Frontiers in Cellular Neuroscience·Sarah Jäkel, Anna Williams
Apr 1, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maria EvangelidouLesley Probert
Jul 3, 2020·Journal of Internal Medicine·L Kular, M Jagodic
Jul 19, 2021·Journal of Neuroimmunology·Maria IvanovaMaria Zakharova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here